In this video segment, Dr. Peter Buckley addresses 2 questions:
• What factors do you consider when you offer depot medications to a patient with schizophrenia?
• What can be done to encourage the use of depot medications?
New evidence links vitamin D status with cognition in patients with psychosis.
Risk Factors for Suicidality in Patients With Schizophrenia ©R_Szatkowski/Shutterstock